ARCHIVES

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

This article is from The Cancer Letter archive.

Vol. 22 No. 46 | November 29, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible

May 20, 1988